Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-12-15FDA Approved: METOPROLOL SUCCINATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved METOPROLOL SUCCINATE as a generic via an Original Application (ANDA) for Mylan Pharmaceuticals Inc.
-
FDA approval · 2011-12-14FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for BYSTOLIC (nebivolol hydrochloride).
-
FDA approval · 2011-12-14FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EDARBI (azilsartan kamedoxomil) submitted by Azurity Pharmaceuticals, Inc. The action approves c…
-
FDA approval · 2011-12-14FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for the generic fixed-dose combination of spironolactone and hydrochlorothiazide from Sun Pharmaceut…
-
FDA approval · 2011-12-12FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for amlodipine besylate and benazepril hydrochloride tablets by Dr. Reddy's Laboratories, expanding …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-12-12FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA supplemental approval for amlodipine besylate and benazepril hydrochloride, a combination antihypertensive, submitted by Dr. Reddy's Lab…
-
FDA approval · 2011-12-12FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Diovan HCT (valsartan/hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporation…
-
FDA approval · 2011-12-09FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's original ANDA for the generic fixed-dose combination triamterene/hydrochlorothiazide.
-
FDA approval · 2011-12-07FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approves a supplemental application for EXFORGE (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation. The actio…
-
FDA approval · 2011-12-07FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) submitted by Novartis Pharmaceuticals…
-
FDA approval · 2011-12-06FDA Approved: CLONIDINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals' clonidine hydrochloride original application, providing a generic version of the antihypertensive agen…
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: Accomplices of Insulin Resistance in Prehypertension: Aldosterone?
A completed clinical trial from Taipei Veterans General Hospital investigated the relationship between aldosterone, insulin resistance, and …
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2) [Phase 2]
This is a Phase 2 clinical trial update evaluating sodium nitroprusside for blood pressure reduction in ICU patients. The study status is co…
-
CLINICAL_TRIALS trial_result · 2011-12-05Clinical Trial Update: Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating the effects of selective and nonselective cyclooxygenase inhibition on arterial blood pressure…
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: Effect of Ginseol Kg1 on Blood Pressure Lowering [Phase 3]
Phase 3 clinical trial update evaluating Ginseol Kg1 for lowering blood pressure in individuals with prehypertension or stage I hypertension…
-
FDA approval · 2011-11-29FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Verapamil Hydrochloride from Chartwell RX, LLC.
-
FDA approval · 2011-11-29FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Moexipril hydrochloride from Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS research · 2011-11-29Clinical Trial Update: Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia [Phase 4]
This is a Phase 4 clinical trial update examining the effects of fish oil supplementation on vascular function in hypertensive patients with…
-
FDA approval · 2011-11-28FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for generic atenolol from Rising Pharma Holdings, Inc. under the ANDA.
-
FDA approval · 2011-11-28FDA Approved: QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Quinapril Hydrochloride/Hydrochlorothiazide from Aurobindo Pharma Limited, granting approval of …
-
FDA approval · 2011-11-28FDA Approved: SPIRONOLACTONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for spironolactone filed by Amneal Pharmaceuticals LLC, a generic product. The approval confirms cha…
-
FDA approval · 2011-11-28FDA Approved: FELODIPINE — Original Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's felodipine generic tablet under an Original Application (ANDA 202170). Felodipine is a ca…
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg [Phase 3]
A Phase 3 trial comparing valsartan 160 mg vs 320 mg for hypertension has completed. The trial was sponsored by Novartis.
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes [Phase 4]
Phase 4 trial update evaluating morning vs evening dosing of valsartan and lisinopril in patients with diabetes and hypertension.
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3) [Phase 4]
Phase 4 trial update reporting safety and efficacy results for MK-0954A in combination therapy for hypertension; study completed with result…